迷你马的反复评估:78例 (2002年至2023年)
Ari Merari1, Langdon Fielding1
1Loomis Basin Equine Medical Center, Penryn, California, USA.
概括
迷你马匹的存活率很高,通常通过阴道分娩解决. 然而,小子的生存率仍然很低, 凸显了改善干预和培训的必要性.
科学领域:
- 动物医学
- 马类繁殖
- 纯血统科学
背景情况:
- 在马类繁殖中,dystocia是一个重大挑战.
- 由于它们的大小, 小马在产后可能会遇到独特的并发症.
研究的目的:
- 综合分析微型马匹的静止病例.
- 确定影响马匹和小羊生存的关键因素.
- 评估不同校正方法的有效性.
主要方法:
- 一项回顾性研究分析了78例迷你马匹的dystocia.
- 从2002年1月到2023年6月收集的数据.
- 涉及一个大型马匹转诊医院和实地服务.
主要成果:
- 马的存活率高达94%,而小的存活率只有17%.
- 常见的缩原因包括肢体异常呈现 (27%),部曲 (23%),尾部呈现 (17%).
- 通过控制或辅助的阴道分娩解决了大多数病例 (80%),而剖腹产在17%的情况下.
结论:
- 微型马匹表现出强大的抗性.
- 在大多数情况下,阴道输送方法是有效的.
- 对于提高子生存率至关重要的是子护理和管理方面的紧急进展.
相关概念视频
Effects of EDTA on End-Point Detection Methods
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


